US 10875912
EGFL6 specific monoclonal antibodies and methods of their use
granted A61KA61K2039/505A61K9/0019
Quick answer
US patent 10875912 (EGFL6 specific monoclonal antibodies and methods of their use) held by The Board of Regents of the University of Texas System expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K9/0019, A61P, A61P35/00